« Back Research in Social and Administrative Pharmacy

Article in Press

Development of a new scale to measure self-reported medication nonadherence

  • Elizabeth J. Unni, M.B.A., Ph.D.

      Affiliations

    • Department of Pharmaceutical Sciences, University of Southern Nevada, 10920 South Riverfront Parkway, South Jordan, UT 84095, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 801 878 1092; fax: +1 801 302 0768.
    • ,
  • Karen B. Farris, Ph.D.

      Affiliations

    • Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA

Published online 12 October 2009 Corrected Proof

References 

  1. Osterberg L, Blaschke T. Adherence to medications. N Engl J Med. 2005;353:487–497
  2. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331–342
  3. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–312
  4. Van Wjik BLG, Klungel OH, Heerdink ER, De Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medications: a systematic review. Ann Pharmacother. 2005;39:319–328
  5. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209
  6. Morrison A, Wertheimer AI. Compilation of quantitative overviews of studies of adherence. Drug Inf J. 2004;38(2):197–210
  7. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–549
  8. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholtz CD, Mukherjee J. Can simple clinical measures detect patient noncompliance?. Hypertension. 1980;2:757–764
  9. Haynes RB, Taylor DW, Sackett DL. Compliance in Healthcare. Baltimore, MD: The Johns Hopkins University Press; 1979;
  10. Ley P. Communicating With Patients. London: Crume Helm; 1988;
  11. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567
  12. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74
  13. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of the medication. Psychol Health. 1999;14:1–24
  14. Brooks CM, Richards JM, Kohler CL, et al. Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales. Med Care. 1994;32(3):298–307
  15. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288–1293
  16. Bruckert E, Simonetta C, Giral P. Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3854 patients with hyperlipidemia: CREOLE study team. J Clin Epidemiol. 1999;52:589–594
  17. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm. 1993;50:91–95
  18. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497
  19. National Heart Lung and Blood Institue. Signs and symptoms of asthma. Accessed on April 17, 2007.
  20. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother. 2001;35(9):997–1003
  21. Johnson MJ. The medication adherence model. A guide for assessing medication taking. Res Theory Nurs Pract. 2002;16(3):179–192
  22. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making?. Soc Sci Med. 1992;34(5):507–513
  23. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782–1787
  24. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services. 2001;52(12):1615–1620
  25. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166(17):1829–1835
  26. Svensson S, Kjellgren KI. Adverse events and patients' perceptions of antihypertensive drug effectiveness. J Hum Hypertens. 2003;17(10):671–675
  27. Foley KA, Hansen L. Understanding patient beliefs to design medication adherence messaging [poster]. Presented at: International Society for Pharmacoeconomics & Outcomes Research (ISPOR) Annual Conference; May 31–24, 2006; Philadelphia, PA.
  28. John E, Farris KB. Understanding medication beliefs among older adults who intentionally and unintentionally miss their medicines. Paper presented at: Mid-west Social and Administrative Pharmacy Meeting; July 27–29, 2006;Minneapolis, MN.
  29. Hays RD. The Medical Outcomes Study Measures of Patient Adherence. RAND. http://www.rand.org/health/surveys_tools/mos/mos_adherence_survey.pdf. Accessed on March 25, 2006.
  30. Nunnally JC, Bernstein IH. The Assessment of Reliability in Psychometric Theory. 3rd ed.. New York: McGraw Hill; 1994;Series in Psychology
  31. Cohen J. A coefficient of agreement for nominal scale. Educ Psychol Meas. 1960;20:37–46
  32. Krigsman K, Nilsson JLG, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120–1128
  33. Stack RJ, Elliott RA, Noyce PR, Bundy C. A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Diabet Med. 2008;25(10):1204–1210

PII: S1551-7411(09)00076-X

doi: 10.1016/j.sapharm.2009.06.005

« Back Research in Social and Administrative Pharmacy

Article in Press

Article Tools